Cargando…
Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
AIMS: First, to compare clinical features and biological disease modifying anti-rheumatic drugs (bDMARDs) response in patients with axial spondyloarthritis (axSpA) and axial psoriatic arthritis (axPsA). Second, to identify possible predictors of treatment response in both entities. METHODS: One-year...
Autores principales: | Benavent, Diego, Plasencia-Rodríguez, Chamaida, Franco-Gómez, Karen, Nieto, Romina, Monjo-Henry, Irene, Peiteado, Diana, Balsa, Alejandro, Navarro-Compán, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675867/ https://www.ncbi.nlm.nih.gov/pubmed/33240404 http://dx.doi.org/10.1177/1759720X20971889 |
Ejemplares similares
-
Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
por: Benavent, Diego, et al.
Publicado: (2022) -
Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review
por: Navarro-Compán, Victoria, et al.
Publicado: (2017) -
Association between concomitant csDMARDs and clinical response to TNF inhibitors in overweight patients with axial spondyloarthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2019) -
Poor health and functioning in patients with axial spondyloarthritis
during the COVID-19 pandemic and lockdown: REUMAVID study (phase
1)
por: Benavent, Diego, et al.
Publicado: (2022) -
Comment on: Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization
por: Benavent, Diego, et al.
Publicado: (2021)